Liver Volume, Portal Vein Flow, and Clearance of Indocyanine Green and Antipyrine in Hyperthyroidism before and after Antithyroid Treatment

References

• Fong TL, McHutchison JG, Reynolds TB. Hyperthyroidism and hepatic dysfunction. A case series analysis. J Clin Gastroenterol 1992;14:240–4.
   Google Scholar
• Thompson PJ, Strum D, Boehm T, Wartofsky L. Abnormalities of liver function tests in tyrotoxicosis. Mil Med 1978;143:548–51.
   PubMedGoogle Scholar
• Davis PJ, Davis FB. Hyperthyroidism in patients over the age of 60 years. Clinical features in 85 patients. Medicine (Baltimore) 1974;53:161–81.
   PubMed Web of Science ®Google Scholar
• Vassilopoulou-Sellin JH. Werner’s and Ingbar’s the thyroid. A fundamental and clinical text. 6th ed. New York: J.B. Lippincott; 1991.
   Google Scholar
• Shenfield GM. Influence of thyroid dysfunction on drug pharmacokinetics. Clin Pharmacokinet 1981;6:275–97.
   PubMed Web of Science ®Google Scholar
• Sonne J. Factors and conditions affecting the glucuronidation of oxazepam. Pharmacol Toxicol 1993;73 Suppl 1:1–23.
   PubMedGoogle Scholar
• Riddell JG, Neill JD, Kelly JG, McDevitt DG. Effects of thyroid dysfunction on propranolol kinetics. Clin Pharmacol Ther 1980;28:565–74.
   PubMed Web of Science ®Google Scholar
• Myers JD, Brannon ES, Holland BC. A correlate study of the cardiac output and the hepatic circulation in hyperthyroidism. J Clin Invest 1950;29:1069–77.
   Google Scholar
• Teunissen MW, van der Veen EA, Doodeman PJ, Breimer DD. Influence of mild thyroid dysfunction on antipyrine clearanceand metabolite formation in man. Eur J Clin Pharmacol 1984; 27:99–103.
   PubMedGoogle Scholar
• Eichelbaum M, Bodem G, Gugler R, Schneider-Deters D, Dengler HJ. Influence of thyroid status on plasma half-life of antipyrine in man. N Engl J Med 1974;290:l040–2.
   Google Scholar
• Vesell ES, Shapiro JR, Passananti T, Jorgensen H, Shively CA. Altered plasma half-lives of antipyrine, propylthiouracil, and methimazole in thyroid dysfunction. Clin Pharmacol Ther 1975;17:48–56.
   Google Scholar
• Nayak VK, Desai NK, Kshirsagar NA, Bhandarkar SD, Satoskar RS. Antipyrine and doxycycline pharmacokinetics in patients with thyroid disorders. J Postgrad Med 1991;37:5–8.
   Google Scholar
• Farrell GC. Drug metabolism in extrahepatic diseases. Pharmacol Ther 1987;35:375–404.
   PubMed Web of Science ®Google Scholar
• Homeida M, Roberts CJ, Halliwell M, Read AE, Branch RA. Antipyrine clearance per unit volume liver: an assessment of hepatic function in chronic liver disease. Gut 1979;20:596–601.
   Google Scholar
• Jackson L, Homeida M, Roberts CJ. The features of hepatic enzyme induction with glutethimide in man. Br J Clin Pharmacol 1978;6:525–8.
   PubMedGoogle Scholar
• Roberts CJ, Jackson L, Halliwell M, Branch RA. The relationship between liver volume, antipyrine clearance and indocyanine green clearance before and after phenobarbitone administration in man. Br J Clin Pharmacol 1976;3:907–13.
   PubMed Web of Science ®Google Scholar
• Reichel C, Block W, Skodra T, Traber F, Schiedermaier P, Spengler U, et al. Relationship between cytochrome P-450 induction by rifampicin, hepatic volume and portal blood flow in man. Eur J Gastroenterol Hepatol 1997;9:975–9.
   PubMedGoogle Scholar
• Crom WR, Webster SL, Bobo L, Teresi ME, Relling MV, Evans WE. Simultaneous administration of multiple model substrates to assess hepatic drug clearance. Clin Pharmacol Ther 1987; 41:645–50.
   PubMedGoogle Scholar
• Villeneuve JP, Huot R, Marleau D, Huet PM. The estimation of hepatic blood flow with indocyanine green: comparison between the continuous infusion and single injection methods. Am J Gastroenterol 1982;77:233–7.
   PubMed Web of Science ®Google Scholar
• Tygstrup N. Assessment of liver function: principles and practice. J Gastroenterol Hepatol 1990;5:468–82.
   PubMedGoogle Scholar
• Ott P, Keiding S, Bass L. Plasma elimination of indocyanine green in the intact pig after bolus injection and during constant infusion: comparison of spectrophotometry and high-pressure liquid chromatography for concentration analysis. Hepatology 1993;18:1504–15.
   Google Scholar
• Dossing M, Poulsen HE, Andreasen PB, Tygstrup N. A simple method for determination of antipyrine clearance. Clin Pharmacol Ther 1982;32:392–6.
   PubMed Web of Science ®Google Scholar
• Altman DG. Practical statistics for medical research. London: Chapman & Hall; 1997.
   Google Scholar
• Rasmussen SN. Liver volume determination by ultrasonic scanning. Copenhagen: Lægeforeningens forlag; 1977.
   Google Scholar
• Skak C, Keiding S. Methodological problems in the use of indocyanine green to estimate hepatic blood flow and ICG clearance in man. Liver 1987;7:155–62.
   PubMedGoogle Scholar
• Burns E, Triger DR, Tucker GT, Bax ND. Indocyanine green elimination in patients with liver disease and in normal subjects. Clin Sci (Colch) 1991;80:155–60.
   Google Scholar
• Burczynski FJ, Pushka KL, Sitar DS, Greenway CV. Hepatic plasma flow: accuracy of estimation from bolus injections of indocyanine green. Am J Physiol 1987;252:H953–62.
   Google Scholar
• Bolondi L, Gaiani S, Barbara L. Accuracy and reproducibility of portal flow measurement by Doppler US. J Hepatol 1991;13: 269–73.
   Google Scholar
• Fillinger MF, Schwartz RA. Volumetric blood flow measurement with color Doppler ultrasonography: the importance of visual clues. J Ultrasound Med 1993;12:123–30.
   PubMedGoogle Scholar
• Burns PN, Jaffe CC. Quantitative flow measurements with Doppler ultrasound: techniques, accuracy, and limitations. Radiol Clin North Am 1985;23:641–57.
   PubMedGoogle Scholar
• Vries P, Hattum J, Hoekstra J, Hooge P. Duplex Doppler measurements of portal venous flow in normal subjects. Inter- and intra-observer variability. J Hepatol 1991;13:358–63.
   Google Scholar
• Bach B, Hansen JM, Kampmann JP, Rasmussen SN, Skovsted L. Disposition of antipyrine and phenytoin correlated with age and liver volume in man. Clin Pharmacokinet 1981;6:389–96.
   Google Scholar
• Swift CG, Homeida M, Halliwell M, Roberts CJ. Antipyrine disposition and liver size in the elderly. Eur J Clin Pharmacol 1978;14:149–52.
   PubMed Web of Science ®Google Scholar
• Greenblatt DJ, Divoll M, Abernethy DR, Harmatz JS, Shader RI. Antipyrine kinetics in the elderly: prediction of age-related changes in benzodiazepine oxidizing capacity. J Pharmacol Exp Ther 1982;220:120–6.
   Google Scholar
• Poulsen HE, Loft S. Antipyrine as a model drug to study hepatic drug-metabolizing capacity. J Hepatol 1988;6:374–82.
   PubMed Web of Science ®Google Scholar
• Marchesini G, Bua V, Brunori A, Bianchi G, Pisi P, Fabbri A, et al. Galactose elimination capacity and liver volume in aging man. Hepatology 1988;8:1079–83.
   PubMed Web of Science ®Google Scholar